Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 04, 2019
Altasciences announced the addition of Dr. Lynne LeSauteur, PhD, to their bioanalytical management team, responsible for the Bioanalytical Services department in the US and the Ligand Binding team in Canada.
read more
Wednesday, November 01, 2023
Altasciences announced the completion of its newly expanded, 8,000-square-foot space, which includes a test material department, features state-of-the-art equipment and forty-eight workbenches, with a vast range of services, including ligand binding ...
read more
Thursday, September 30, 2021
Altasciences announced the continued expansion of their formulation, manufacturing, and analytical services facilities in Philadelphia, PA. Altasciences, an integrated drug development solution company offering pharmaceutical and biotechnology ...
read more
Wednesday, November 24, 2021
Altasciences, a drug development solution company, announced the completion of a second expansion of their ligand binding laboratory to meet the high demand for quality bioanalytical services.
read more
Altasciences announced that construction work has begun on the expansion of their ligand binding laboratory to meet the high demand for quality bioanalytical services.
read more
Altasciences have entered into an agreement with Amador Bioscience, a translational and consulting clinical research organization located in China and the U.S.
read more
ALTEN Calsoft Labs has launched – "BioPharma Ledger," a Blockchain clinical trial platform.
read more
Tuesday, February 26, 2013
Althea Technologies, Inc., a leading provider of biopharmaceutical development and manufacturing services, and Profectus BioSciences Inc, a technology based vaccine company, today announced the signing of a manufacturing supply agreement for plasmid ...
read more
Tuesday, September 25, 2012
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products, announced today the promotion of Rick Hancock to the position of President and CEO, Chris Duffy to Senior Vice President of ...
read more
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceutical products, announced today the appointment of Dr. Kristin DeFife as Director, Biologics Manufacturing, and Jack Wright as VP, Sales and ...
read more
Althea Technologies, a leading provider of development and manufacturing services for biopharmaceutical products, today announced that Dennis Fenton, Ph.D., will chair Althea’s Scientific Advisory Board and be appointed as Board Observer. Dr. Fenton ...
read more
Wednesday, March 17, 2021
Altimmune has expanded its previously-announced AdCOVID™ manufacturing collaboration with Lonza.
read more
CMC ICOS Biologics, Inc. and Altor BioScience Corporation have entered into a manufacturing agreement for the cGMP manufacturing of Altor’s ALT-803 molecule for use in Phase 3 clinical trials.
read more
Altruist Biologics, an Innovent Biologics subsidiary and contract development and manufacturing organization (CDMO), announced that its Hangzhou facility was granted the Drug Product Manufacturing License (C Certificate) from the Chinese National ...
read more
SmartCelle is Altus Formulation's proprietary polymeric micellar technology for parenteral, oral and topical delivery of insoluble molecules.
read more